跳至主要内容
临床试验/NL-OMON20251
NL-OMON20251已完成不适用

Enhancement of exposure therapy for social anxiety disorder with testosterone: A proof-of-concept randomized placebo-controlled trial

Prof. dr. Karin Roelofs-Radboud University Nijmegen, Behavioural Science Institute (BSI) & Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Postbus 9101, 6500 HB Nijmegen-Leiden University, Faculty of Social and BehaviouralSciences, Institute of PsychologyWassenaarseweg 52, 2333 AK LeidenK.roelofs@donders.ru.nl0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Woman, 18-45 years old
  • - Social Anxiety Disorder (SAD) as established with a structured interview (MINI), and with speech anxiety as primary fear

排除标准

  • - Prior non response to exposure therapy (i.c. speech exposure) for SAD symptoms, as defined by the patient’s report of receiving specific and regular exposure assignments as part of previous therapy.
  • - Entry of patients with other mood or anxiety disorders will be permitted in order to increase accrual of a clinically relevant sample; however in cases where SAD is not judged to be the predominant disorder, participants will not be eligible.

研究者

发起方
Prof. dr. Karin Roelofs-Radboud University Nijmegen, Behavioural Science Institute (BSI) & Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Postbus 9101, 6500 HB Nijmegen-Leiden University, Faculty of Social and BehaviouralSciences, Institute of PsychologyWassenaarseweg 52, 2333 AK LeidenK.roelofs@donders.ru.nl

相似试验

Testosterone enhancement of exposure therapy in... | 临床试验